Federal Judge Rules In Favor Of Sanofi, Regeneron In Patent Suit Over Cholesterol Drugs

The decision was a loss for Amgen, which had claimed that Sanofi and Regeneron’s drug Praluent infringed on its patents for the drug Repatha.

from Above the Law https://ift.tt/2zvQBsn
via Solicitors In Lagos Nigeria



from WordPress https://ift.tt/2LgImph
via Law firms in Nigeria

Comments

Popular posts from this blog

Morning Docket: 10.07.19

Morning Docket: 12.18.19

Morning Docket: 04.06.20